"The emails and phone calls asking where to purchase Cefaly® have been non-stop since we announced the device would be made available in the United States"
After much anticipation, CEFALY Technology announced today that the Cefaly® medical device for the preventative treatment for migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at www.cefaly.us
The Cefaly® medical device received U.S. Food and Drug Administration (FDA) approval for the preventative treatment for migraine headaches on March 11, 2014. It is the first transcutaneous electrical nerve stimulation device specifically authorized for use prior to the onset of pain.
"The emails and phone calls asking where to purchase Cefaly® have been non-stop since we announced the device would be made available in the United States," said Doctor Pierre Rigaux, the chief executive officer of CEFALY Technology, the Belgian maker and member of the inventors team of the Cefaly®. "I'm very happy to let migraine sufferers in the U.S. know that Cefaly is now ready for U.S. purchase for patients with a prescription."
Cefaly® is a battery-powered device that resembles a headband and is affixed to the center of the forehead using a self-adhesive electrode that applies an electric current to the skin and underlying body tissues to stimulate branches of the trigeminal nerve, which has been associated with migraine headaches.
The company that manufactures Cefaly® expects to make the device available via select pharmacies and clinics in the months ahead. For now, the device is available for U.S. purchase at www.cefaly.us
Cefaly® is also available in Canada and Europe.
CEFALY Technology is a Belgium-based company specializing in electronics for medical applications. It has developed external cranial stimulation technology for applications in the field of neurology, and in particular for treating migraines and headaches. For additional information or to purchase Cefaly® visit www.cefaly.us